Background: Radiation therapy (RT) for prostate cancer (PCa) treatment is burdened by high rates of late urinary adverse events (UAEs). The feasibility of robot-assisted cystectomy (RAC) with intracorporeal urinary diversion (ICUD) for treatment of high-grade UAEs has never been assessed. Objective: To report perioperative outcomes, early (≤90 d) and late (>90 d) complications among patients undergoing RAC for UAEs after RT. Design, setting, and participants: We retrospectively evaluated 32 patients undergoing RAC with ICUD for UAEs in a single tertiary centre. Surgical procedure: Surgery was performed using a da Vinci Xi system with adaptation for the primary treatment. Measurements: Perioperative outcomes included estimated blood loss (EBL), operative time (OT), intraoperative complications, and length of stay (LOS). Data for early and late postoperative complications were collected using the quality criteria recommended by the European Association of Urology. Univariate logistic regressions were performed to test the effect of baseline and perioperative characteristics on early postoperative complications. Results and limitations: The median age-adjusted Charlson comorbidity index (ACCI) was 6 (IQR 5–7). The indication for RAC was hemorrhagic radiation cystitis in 29 cases (91%), contracted bladder in two cases (6.2%), and urinary fistula in one case (3.1%). The median EBL, OT, and LOS were 250 ml, 330 min, and 10 d, respectively. A total of 31 (97%) patients received an ileal conduit. The 90-d rate of Clavien-Dindo grade ≥IIIa complications was 28%. The late complication rate was 46% and the perioperative mortality rate was 0%. On univariate analyses, ACCI was the only parameter correlated with the risk of early complications (odds ratio 1.75, 95% confidence interval 1.05–2.9; p = 0.03). The median follow-up was 30 mo (IQR 15–40). The lack of comparison with open cystectomy represents the main limitation. Conclusions: RAC for UAEs in patients with a history of pelvic irradiation is a feasible option in high-volume centers. The use of new technologies can help to overcome some of the technical difficulties and reduce the risk of perioperative and late complications. Patient summary: We report our experience with robot-assisted surgery for removal of the bladder in the management of urinary problems after radiation therapy for prostate cancer. When performed by highly experienced surgeons, this is a feasible procedure with outcomes and early and late complication rates that are acceptable.

Robot-assisted Cystectomy with Intracorporeal Urinary Diversion After Pelvic Irradiation for Prostate Cancer: Technique and Results from a Single High-volume Center / Piazza, P.; Rosiello, G.; Chacon, V. T.; Puliatti, S.; Amato, M.; Farinha, R.; Schiavina, R.; Brunocilla, E.; Berquin, C.; Develtere, D.; Sinatti, C.; Van Puyvelde, H.; De Groote, R.; Schatteman, P.; De Naeyer, G.; D'Hondt, F.; Mottrie, A.. - In: EUROPEAN UROLOGY. - ISSN 0302-2838. - 80:4(2021), pp. 489-496. [10.1016/j.eururo.2021.03.023]

Robot-assisted Cystectomy with Intracorporeal Urinary Diversion After Pelvic Irradiation for Prostate Cancer: Technique and Results from a Single High-volume Center

Puliatti S.;
2021

Abstract

Background: Radiation therapy (RT) for prostate cancer (PCa) treatment is burdened by high rates of late urinary adverse events (UAEs). The feasibility of robot-assisted cystectomy (RAC) with intracorporeal urinary diversion (ICUD) for treatment of high-grade UAEs has never been assessed. Objective: To report perioperative outcomes, early (≤90 d) and late (>90 d) complications among patients undergoing RAC for UAEs after RT. Design, setting, and participants: We retrospectively evaluated 32 patients undergoing RAC with ICUD for UAEs in a single tertiary centre. Surgical procedure: Surgery was performed using a da Vinci Xi system with adaptation for the primary treatment. Measurements: Perioperative outcomes included estimated blood loss (EBL), operative time (OT), intraoperative complications, and length of stay (LOS). Data for early and late postoperative complications were collected using the quality criteria recommended by the European Association of Urology. Univariate logistic regressions were performed to test the effect of baseline and perioperative characteristics on early postoperative complications. Results and limitations: The median age-adjusted Charlson comorbidity index (ACCI) was 6 (IQR 5–7). The indication for RAC was hemorrhagic radiation cystitis in 29 cases (91%), contracted bladder in two cases (6.2%), and urinary fistula in one case (3.1%). The median EBL, OT, and LOS were 250 ml, 330 min, and 10 d, respectively. A total of 31 (97%) patients received an ileal conduit. The 90-d rate of Clavien-Dindo grade ≥IIIa complications was 28%. The late complication rate was 46% and the perioperative mortality rate was 0%. On univariate analyses, ACCI was the only parameter correlated with the risk of early complications (odds ratio 1.75, 95% confidence interval 1.05–2.9; p = 0.03). The median follow-up was 30 mo (IQR 15–40). The lack of comparison with open cystectomy represents the main limitation. Conclusions: RAC for UAEs in patients with a history of pelvic irradiation is a feasible option in high-volume centers. The use of new technologies can help to overcome some of the technical difficulties and reduce the risk of perioperative and late complications. Patient summary: We report our experience with robot-assisted surgery for removal of the bladder in the management of urinary problems after radiation therapy for prostate cancer. When performed by highly experienced surgeons, this is a feasible procedure with outcomes and early and late complication rates that are acceptable.
2021
80
4
489
496
Robot-assisted Cystectomy with Intracorporeal Urinary Diversion After Pelvic Irradiation for Prostate Cancer: Technique and Results from a Single High-volume Center / Piazza, P.; Rosiello, G.; Chacon, V. T.; Puliatti, S.; Amato, M.; Farinha, R.; Schiavina, R.; Brunocilla, E.; Berquin, C.; Develtere, D.; Sinatti, C.; Van Puyvelde, H.; De Groote, R.; Schatteman, P.; De Naeyer, G.; D'Hondt, F.; Mottrie, A.. - In: EUROPEAN UROLOGY. - ISSN 0302-2838. - 80:4(2021), pp. 489-496. [10.1016/j.eururo.2021.03.023]
Piazza, P.; Rosiello, G.; Chacon, V. T.; Puliatti, S.; Amato, M.; Farinha, R.; Schiavina, R.; Brunocilla, E.; Berquin, C.; Develtere, D.; Sinatti, C.; Van Puyvelde, H.; De Groote, R.; Schatteman, P.; De Naeyer, G.; D'Hondt, F.; Mottrie, A.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1249786
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 8
  • ???jsp.display-item.citation.isi??? 0
social impact